Company & Brand

Medytox R&D

Medytox's Microbial R&D Center was established in2001. It specialises... Show Description

Botulinum toxin

Botulinum toxin is a protein produced by the bacterium... Show Description

Neuronox®

Neuronox® is a prescription medicine that is injected into mus... Show Description
Medytox Academy
Lecture Differentiate and diverse lectures of famous lecturers, injection video and etc are available for Drs who are busy with patients... Read More
Clinical article clinical thesis of Neuronox® which is globally used over 25 countries and clinical trial remarks are available for Drs. Read More
Partnership
Material archive
Press the Download button to download the PDF and so on file

Medytox Mini Poll

Which area do your patients most want to be treated with Neuronox?
a. Glabellar lines
b. Crow’s feet
c. Forehead lines
d. Masseter
e. Calf

Medytox News

  • Allergan, Inc. and Medytox...
     IRVINE, Calif. & SEOUL, Korea--(BUSINESS WIRE)-- Allergan, Inc., (NYSE: AGN) and Medytox, Inc. Announced that they have entered into a license agreement pursuant to which, upon closing, Allergan will pay Medytox an upfront payment of U.S. $65 million and Medytox will grant Allergan exclusive rights, worldwide outside of Korea, to develop and, if approved, commercialize certain neurotoxin product candidates currently in development, including a potential liquid-injectable product. Pursuant to the agreement, Allergan has also agreed to make additional contingent payments, including up to an aggregate of U.S. $116.5 million upon achieving certain development milestones, up to an aggregate of U.S. $180.5 million upon achieving certain commercialization milestones, and royalties on product sales. The closing of the transaction is contingent on obtaining certain government approvals. 

     

    2013-10-11
  • Medytox Participated in Br...

    Medytox participated in the 2013 Brazilian Dermatologist Congress which is the biggest local dermatologist congress in Latin America.

    We presented mainly Neuronox®(Botulift®) at the booth with a lot of interest of participants .

    Also there was satellite symposium with the topic Botulift®, Presentation of a new botulinum toxin’. The Chairman & Speaker was Dr. Sergio Talarico, and Dra. Carl de Sanctis, Dra. Laura Bariquelo Buratini, Dra. Monica Manela Azulay had participated as a panels. It has been successfully appealed to an audience that why Botulift® can be the optimal botulinum toxin product in their practice. 

     

    2013-09-30
  • Medytox Participated in Du...
    Medytox participated in the Dubai Derma 2013 (Dubai World Dermatology and Laser Conference & Exhibition) which is the largest conference in the middle east. We presented Neuronox and Neuramis at our booth. Also, we had special gala dinner Medytox Night with Iranian doctors.
    2013-08-23
  • Medytox Participated in AM...

    We had a great time at AMWC!

    Many doctors showed interest in our products, Neuronox® and Neuramis®,

    and the "beauty of Korea" event, participants had a chance to have photo shoots wearing traditional costume of Korea.

    We also celebrated the completion cGMP with Champagne, and run the lucky draw to provide samples of Neuramis® to doctors.

     

     

    2013-08-22
  • Medytox in IPRAS 2013
    Medytox participated in IPRAS 2013. (Feb. 4-Mar. 1, 2013)
    We had Neuronx style party to celebrate sales growth with champagne.
    During the congress, over thousand visitors stopped by Medytox booth and
    showed great interest in Neuronox and Neuramis.
    2013-03-18
  • Medytox in IMCAS Paris 2013
    Medytox participated in IMCAS Paris 2013. (Feb. 1 - 3, 2013)
    We promoted the publication of the new articles about Neuronox in Dermatologic Surgery.
     
    2013-03-18
  • Siax appeared in TV progra...
    Global Skin, Medytox’s partner in Dominica, supported for a section with botulinum toxin using Siax. It was appreared in the TV probram "Diario de Belleza" in December 1st 2012.
     
    Please refer to the link below.
    2013-02-05
  • Celeste participated in IT...
    Celeste, Medytox’s partner in Thailand, parcipated in ITCAM (International Thaicosderm Congress On Aesthetic Medicine). Professor Kim bum joon and Dr. Kyle Seo were invited as speakers.
    Prof. Kim had a lecture in luncheon symposium with the subject of Comparison Guideline of BTX-A Between Asian & Western Countries. And, Dr. Seo lectured on Lower Face Rejuvenation Using BTX-A in hands-on workshop. The symposium and workshop sponsored by Medytox and Celeste were very well-received by all participants.
    Thanks to their great lectures, all participants showed great interest in various treatments with Neuronox.
    2012-11-19

See More News